pyridoxine hydrochloride : The hydrochloride salt of pyridoxine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 6019 |
| CHEMBL ID | 1200756 |
| CHEBI ID | 30961 |
| SCHEMBL ID | 42293 |
| MeSH ID | M0329794 |
| Synonym |
|---|
| MLS002153915 |
| 3,4-pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride |
| pyridoxol hydrochloride |
| pydox |
| vitamin b6-hydrochloride |
| 3-hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride |
| tex six t.r. |
| hexavibex |
| pyridoxol, hydrochloride |
| 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine hydrochloride |
| beesix |
| pyridoxinium chloride |
| benadon |
| pyridoxine hydrochloride |
| wln: t6nj b1 cq d1q e1q &gh |
| pyridipca |
| hexa-betalin |
| 3, 5-hydroxy-6-methyl-, hydrochloride |
| aderomine hydrochloride |
| adermine hydrochloride |
| becilan |
| 5-hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride |
| campoviton 6 |
| hexabetalin |
| hexobion |
| hexermin |
| pyridoxine, hydrochloride |
| nsc-36225 |
| pyridoxine chloride |
| component of alestrol |
| alestrol |
| hexabione hydrochloride |
| vibex |
| pyridox |
| 4,5-bis(hydroxymethyl)-3-hydroxy-2-methylpyridine hydrochloride |
| godabion |
| hexa-betalin (r) |
| aderoxin |
| 3-hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride |
| einecs 200-386-2 |
| pyridoxinum hydrochloricum (hungarian) |
| pyridoxine monohydrochloride |
| rodex (r) |
| ccris 1903 |
| hsdb 1212 |
| bendectin |
| nsc 36225 |
| ai3-19016 |
| bonasanit |
| spondylonal |
| paxadon |
| pyridoxine hcl |
| CHEBI:30961 , |
| PRESTWICK_925 |
| 5-hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride |
| 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride |
| 3-hydroxy-4,5-dimethylol-alpha-picoline hydrochloride |
| NCGC00180946-01 |
| smr000674613 |
| MLS001074329 |
| 4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride |
| pyridoxinum hydrochloricum |
| vitamin b6 hydrochloride |
| aderoxine |
| 58-56-0 |
| pyridoxine hydrochloride, meets usp testing specifications |
| pyridoxine hydrochloride, plant cell culture tested |
| pyridoxine hydrochloride, >=98% (hplc) |
| pyridoxine hydrochloride (b6), analytical standard |
| pyridoxine hydrochloride, bioreagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture |
| D02179 |
| pyridoxine hydrochloride (jp17/usp) |
| hexa-betalin (tn) |
| 8064-77-5 |
| AC-12024 |
| CHEMBL1200756 |
| pyridoxini hydrochloridum |
| P0561 |
| HMS1569N08 |
| dtxsid1040792 , |
| tox21_302476 |
| NCGC00256911-01 |
| dtxcid4010780 |
| unii-68y4cf58bv |
| 3,4-pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride (1:1) |
| pyridoxine hydrochloride [usp:jan] |
| 68y4cf58bv , |
| 5-hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride |
| clorhidrato de piridoxina |
| FT-0631260 |
| vitamin b6, hydrochloride |
| AKOS015891679 |
| pn hcl |
| S3113 |
| bonjesta component pyridoxine hydrochloride |
| pyridoxine hydrochloride component of bonjesta |
| vitamin b6 (as pyridoxine hydrochloride) |
| pyridoxine hydrochloride [mart.] |
| pyridoxine hydrochloride [usp monograph] |
| pyridoxinum hydrochloricum [hpus] |
| tpn component pyridoxine hydrochloride |
| pyridoxine hydrochloride [hsdb] |
| pyridoxine hydrochloride [ep monograph] |
| pyridoxine hydrochloride [ep impurity] |
| pyridoxine hcl [inci] |
| pyridoxine hydrochloride [mi] |
| pyridoxini hydrochloridum [who-ip latin] |
| pyridoxine hydrochloride [usp-rs] |
| pyridoxine hydrochloride [who-ip] |
| pyridoxine hydrochloride [jan] |
| pyridoxine hydrochloride [vandf] |
| bendectin component pyridoxine hydrochloride |
| pyridoxine hydrochloride [fcc] |
| pyridoxine hydrochloride component of bendectin |
| pyridoxine hydrochloride [orange book] |
| pyridoxine hcl [vandf] |
| diclectin component pyridoxine hydrochloride |
| pyridoxine hydrochloride [green book] |
| diclegis component pyridoxine hydrochloride |
| pyridoxine hydrochloride [who-dd] |
| pyridoxine hydrochloride component of tpn |
| CCG-220623 |
| ZUFQODAHGAHPFQ-UHFFFAOYSA-N |
| SCHEMBL42293 |
| F0001-2400 |
| (5-hydroxy-6-methylpyridine-3,4-diyl)dimethanol hydrochloride |
| Q-201647 |
| CS-W020418 |
| pyridoxine (hydrochloride) |
| pyridoxine hydrochloride, british pharmacopoeia (bp) reference standard |
| mfcd00012807 |
| vitamin b6 (hydrochloride) |
| pyridoxol (hydrochloride) |
| SR-05000001644-4 |
| pyridoxine hydrochloride, saj special grade, >=98.0% |
| pyridoxine hydrochloride, 98% |
| pyridoxine hydrochloride, united states pharmacopeia (usp) reference standard |
| pyridoxine hydrochloride, vetec(tm) reagent grade, 98% |
| pyridoxine hydrochloride, european pharmacopoeia (ep) reference standard |
| pyridoxine hydrochloride, p.a., 98-102% |
| pyridoxine hydrochloride, pharmaceutical secondary standard; certified reference material |
| pyridoxine hydrochloride 1.0 mg/ml in methanol (as free base) |
| pyridoxin hydrochloride (vitamin b6 hydrochloride) |
| pyridoxine hydrochloride, certified reference material, tracecert(r) |
| SW197042-3 |
| HY-N0682 |
| Q26841284 |
| AS-11752 |
| 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol;hydrochloride |
| AMY37035 |
| pyridoxol (hydrochloride);vitamin b6 (hydrochloride) |
| H12039 |
| 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine hydrochloride |
| SY061587 |
| EN300-7548938 |
| b-6 pyridoxine hcl |
| pyridoxine hydrochloride (mart.) |
| pyridoxine hydrochloride (usp:jan) |
| rodex(r) |
| pyridoxine hydrochloride (ep impurity) |
| citranatalb-calm |
| pyridoxine hydrochloride (usp-rs) |
| pyridoxine hydrochloride (ep monograph) |
| pyridoxine hci |
| 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol monohydrochloride |
| pyridoxine hydrochloride (usp monograph) |
| 3-hydroxy-4,5-dimethylol-alpha-pic |
| Item | Process | Frequency |
|---|---|---|
| Plant-based foods and beverages | core-ingredient | 430 |
| Plant-based foods | core-ingredient | 412 |
| Cereals and their products | core-ingredient | 399 |
| Cereals and potatoes | core-ingredient | 399 |
| Beverages | core-ingredient | 148 |
| Breakfast cereals | core-ingredient | 127 |
| Breakfasts | core-ingredient | 126 |
| Extruded cereals | core-ingredient | 40 |
| Snacks | core-ingredient | 36 |
| Cereal flakes | core-ingredient | 30 |
| Flakes | core-ingredient | 30 |
| Sweet snacks | core-ingredient | 30 |
| Energy drinks | core-ingredient | 30 |
| Sodas | core-ingredient | 28 |
| Carbonated drinks | core-ingredient | 28 |
| Biscuits and cakes | core-ingredient | 27 |
| Waters | core-ingredient | 26 |
| Cakes | core-ingredient | 24 |
| Corn flakes | core-ingredient | 23 |
| Extruded flakes | core-ingredient | 23 |
| Plant-based beverages | core-ingredient | 19 |
| Beverages and beverages preparations | core-ingredient | 18 |
| Sweetened beverages | core-ingredient | 17 |
| Frozen foods | core-ingredient | 16 |
| Dried products | core-ingredient | 13 |
| Dietary supplements | core-ingredient | 12 |
| Dried products to be rehydrated | core-ingredient | 11 |
| Meats | core-ingredient | 11 |
| Meats and their products | core-ingredient | 11 |
| Dehydrated beverages | core-ingredient | 10 |
| Vegetable fats | core-ingredient | 10 |
| Fats | core-ingredient | 10 |
| Energy drink without sugar and with artificial sweeteners | core-ingredient | 10 |
| en:corn-flakes | core-ingredient | 9 |
| Food additives | core-ingredient | 8 |
| Tea-based beverages | core-ingredient | 8 |
| Artificially sweetened beverages | core-ingredient | 7 |
| Iced teas | core-ingredient | 7 |
| Nutritional yeast | core-ingredient | 6 |
| Peanut butters | core-ingredient | 6 |
| Legume butters | core-ingredient | 6 |
| Oilseed purees | core-ingredient | 6 |
| Plant-based spreads | core-ingredient | 6 |
| Spreads | core-ingredient | 6 |
| Legumes and their products | core-ingredient | 6 |
| Vitamin waters | core-ingredient | 6 |
| Cooking helpers | core-ingredient | 5 |
| Nut butters | core-ingredient | 5 |
| Nuts and their products | core-ingredient | 5 |
| Dietary drink for sport | core-ingredient | 5 |
| Meals | core-ingredient | 5 |
| Frozen meats | core-ingredient | 4 |
| en:Cereals and their products | core-ingredient | 4 |
| en:Cereals and potatoes | core-ingredient | 4 |
| en:Plant-based foods | core-ingredient | 4 |
| en:Plant-based foods and beverages | core-ingredient | 4 |
| Cereal grains | core-ingredient | 4 |
| Seeds | core-ingredient | 4 |
| Céréales et dérivés | core-ingredient | 4 |
| Céréales et pommes de terre | core-ingredient | 4 |
| Aliments d'origine végétale | core-ingredient | 4 |
| Aliments et boissons à base de végétaux | core-ingredient | 4 |
| Energy drink with sugar | core-ingredient | 4 |
| Fruit-based beverages | core-ingredient | 3 |
| Rolled flakes | core-ingredient | 3 |
| Frosted corn flakes | core-ingredient | 3 |
| Porridge | core-ingredient | 3 |
| Dairies | core-ingredient | 3 |
| Condiments | core-ingredient | 3 |
| en:Breakfast cereals | core-ingredient | 3 |
| en:Breakfasts | core-ingredient | 3 |
| Sausages | core-ingredient | 3 |
| Prepared meats | core-ingredient | 3 |
| Rices | core-ingredient | 3 |
| Céréales pour petit-déjeuner | core-ingredient | 3 |
| Petit-déjeuners | core-ingredient | 3 |
| Biscuits | core-ingredient | 3 |
| Confectioneries | core-ingredient | 3 |
| Pasta dishes | core-ingredient | 3 |
| en:breakfast-cereals | core-ingredient | 3 |
| en:artificially-sweetened-beverages | core-ingredient | 3 |
| gazeuses | core-ingredient | 3 |
| Boissons | core-ingredient | 3 |
| Vitamins | core-ingredient | 3 |
| Fruit juices | core-ingredient | 2 |
| Juices and nectars | core-ingredient | 2 |
| Sugars | core-ingredient | 2 |
| Sweeteners | core-ingredient | 2 |
| Rolled oats | core-ingredient | 2 |
| Dairy drinks | core-ingredient | 2 |
| Dairy substitutes | core-ingredient | 2 |
| Breakfast cereals fortified with vitamins and chemical elements | core-ingredient | 2 |
| Suplementos dietéticos | core-ingredient | 2 |
| Meat alternatives | core-ingredient | 2 |
| Diet beverages | core-ingredient | 2 |
| Sandwiches | core-ingredient | 2 |
| Protéines en poudre | core-ingredient | 2 |
| Compléments pour le Bodybuilding | core-ingredient | 2 |
| Compléments alimentaires | core-ingredient | 2 |
| Flavored waters | core-ingredient | 2 |
| en:sweetened-beverages | core-ingredient | 2 |
| Enhaned water | core-ingredient | 2 |
| Beverages with orange | core-ingredient | 1 |
| Cereal with raisins | core-ingredient | 1 |
| Plain porridge | core-ingredient | 1 |
| Frozen seafood | core-ingredient | 1 |
| Seafood | core-ingredient | 1 |
| Plant-based milk al | core-ingredient | 1 |
| Milk substitutes | core-ingredient | 1 |
| Cocoa and its products | core-ingredient | 1 |
| en:rolled-flakes | core-ingredient | 1 |
| Porridge with fruits | core-ingredient | 1 |
| en:Nutritional yeast | core-ingredient | 1 |
| Aditivos alimentarios | core-ingredient | 1 |
| Ayudas culinarias | core-ingredient | 1 |
| Condimentos | core-ingredient | 1 |
| en:cooking-helpers | core-ingredient | 1 |
| and lasco | core-ingredient | 1 |
| Cornflakes | core-ingredient | 1 |
| Cereals with fruits | core-ingredient | 1 |
| Cereal brans | core-ingredient | 1 |
| Wheat flours | core-ingredient | 1 |
| Cereal flours | core-ingredient | 1 |
| Flours | core-ingredient | 1 |
| protein Powder Pro Fit | core-ingredient | 1 |
| Protein powders | core-ingredient | 1 |
| Bodybuilding supplements | core-ingredient | 1 |
| Raisins | core-ingredient | 1 |
| Dried fruits | core-ingredient | 1 |
| Dried plant-based foods | core-ingredient | 1 |
| Fruits based foods | core-ingredient | 1 |
| Fruits and vegetables based foods | core-ingredient | 1 |
| Vegan patties | core-ingredient | 1 |
| Vegetarian patties | core-ingredient | 1 |
| Cold cereal | core-ingredient | 1 |
| Breakfast cereals rich in fibre | core-ingredient | 1 |
| Brea | core-ingredient | 1 |
| Puffed rice | core-ingredient | 1 |
| Puffed cereals | core-ingredient | 1 |
| Puffed grains | core-ingredient | 1 |
| Cereal flakes with fruit | core-ingredient | 1 |
| Rice Krispies | core-ingredient | 1 |
| en:energy-drink-with-sugar | core-ingredient | 1 |
| Coffee-drinks-with-milk | core-ingredient | 1 |
| Coffee drinks | core-ingredient | 1 |
| Chicken sandwiches | core-ingredient | 1 |
| Poultry sandwiches | core-ingredient | 1 |
| Spring waters | core-ingredient | 1 |
| Products for specific diets | core-ingredient | 1 |
| Specific products | core-ingredient | 1 |
| Orange juices | core-ingredient | 1 |
| Drink enhancer | core-ingredient | 1 |
| Biscuits and cakes Cakes | core-ingredient | 1 |
| Oat-flakes | core-ingredient | 1 |
| Lemonade | core-ingredient | 1 |
| en:Vitamin mineral combinations | core-ingredient | 1 |
| Productos sin gluten | core-ingredient | 1 |
| sweetened shredded wheat cereal | core-ingredient | 1 |
| Yogurts | core-ingredient | 1 |
| Fermented dairy desserts | core-ingredient | 1 |
| Dairy desserts | core-ingredient | 1 |
| Fermented milk products | core-ingredient | 1 |
| Desserts | core-ingredient | 1 |
| Fermented foods | core-ingredient | 1 |
| Meat analogues from soy or wheat proteins | core-ingredient | 1 |
| Meat analogues | core-ingredient | 1 |
| Céréales pour petit déjeuner riches en fibres | core-ingredient | 1 |
| Licensed products | core-ingredient | 1 |
| Crackers | core-ingredient | 1 |
| Appetizers | core-ingredient | 1 |
| Salty snacks | core-ingredient | 1 |
| Open Products Facts | core-ingredient | 1 |
| Non food products | core-ingredient | 1 |
| Groceries | core-ingredient | 1 |
| Sauces | core-ingredient | 1 |
| en:flavored-waters | core-ingredient | 1 |
| Flavored bottled water | core-ingredient | 1 |
| Corn | core-ingredient | 1 |
| Rice product | core-ingredient | 1 |
| en:energy-drinks | core-ingredient | 1 |
| Bebidas azucaradas | core-ingredient | 1 |
| Bebidas con sabor | core-ingredient | 1 |
| Bebidas energéticas | core-ingredient | 1 |
| Bebidas no alcohólicas | core-ingredient | 1 |
| Bebidas carbonatadas | core-ingredient | 1 |
| Bebidas | core-ingredient | 1 |
| Bebidas y preparaciones de bebidas | core-ingredient | 1 |
| Boissons sans sucre ajouté | core-ingredient | 1 |
| electrolyte water | core-ingredient | 1 |
| Peach flavored iced teas | core-ingredient | 1 |
| Flavors | core-ingredient | 1 |
| Tea bags | core-ingredient | 1 |
| Teas | core-ingredient | 1 |
| Hot beverages | core-ingredient | 1 |
| Vegan egg yolk | core-ingredient | 1 |
| Chicken nuggets | core-ingredient | 1 |
| Breaded chicken | core-ingredient | 1 |
| Poultry nuggets | core-ingredient | 1 |
| Cooked chicken | core-ingredient | 1 |
| Chicken preparations | core-ingredient | 1 |
| Cooked poultries | core-ingredient | 1 |
| Chickens | core-ingredient | 1 |
| Breaded products | core-ingredient | 1 |
| Poultries | core-ingredient | 1 |
| Meat preparations | core-ingredient | 1 |
| Chicken and its products | core-ingredient | 1 |
| Nutritional Supplement | core-ingredient | 1 |
| Multi-Vitamin | core-ingredient | 1 |
| en:open-beauty-facts | core-ingredient | 1 |
| Cheese substitutes | core-ingredient | 1 |
| Vegetarian meal | core-ingredient | 1 |
| Meal kits | core-ingredient | 1 |
| Meal replacements | core-ingredient | 1 |
| Instant Oatmeal | core-ingredient | 1 |
| Boissons énergisantes | core-ingredient | 1 |
| en:From 10 months | core-ingredient | 1 |
| en:Baby foods | core-ingredient | 1 |
| cereal | core-ingredient | 1 |
| Dried meals | core-ingredient | 1 |
| en:dietary-supplements | core-ingredient | 1 |
| fr:multivitamin | core-ingredient | 1 |
| Effervescent Hydration Electrolyte Tablets | core-ingredient | 1 |
| Class | Description |
|---|---|
| hydrochloride | A salt formally resulting from the reaction of hydrochloric acid with an organic base. |
| vitamin B6 | Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 1.0621 | 0.0032 | 45.4673 | 12,589.2998 | AID2517 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 50.1187 | 0.1000 | 20.8793 | 79.4328 | AID588456 |
| AR protein | Homo sapiens (human) | Potency | 28.1838 | 0.0002 | 21.2231 | 8,912.5098 | AID588515 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 1.0964 | 0.0002 | 14.3764 | 60.0339 | AID720692 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 13.6854 | 0.0002 | 29.3054 | 16,493.5996 | AID743079 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 35.4813 | 0.0501 | 27.0736 | 89.1251 | AID588590 |
| geminin | Homo sapiens (human) | Potency | 29.0929 | 0.0046 | 11.3741 | 33.4983 | AID624296 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 100.0000 | 0.0023 | 19.5956 | 74.0614 | AID651743 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID626548 | Inhibition of Cu2-amyloid beta (1 to 16) complex-induced DTBC oxidation by spectrophotometry | 2011 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21 | Vitamin B6s inhibit oxidative stress caused by Alzheimer's disease-related Cu(II)-β-amyloid complexes-cooperative action of phospho-moiety. |
| AID626542 | Inhibition of Cu2-amyloid beta (1 to 20) complex-induced dopamine oxidation by spectrophotometry | 2011 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21 | Vitamin B6s inhibit oxidative stress caused by Alzheimer's disease-related Cu(II)-β-amyloid complexes-cooperative action of phospho-moiety. |
| AID626544 | Inhibition of Cu2-amyloid beta (1 to 16) complex-induced THB oxidation by spectrophotometry | 2011 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21 | Vitamin B6s inhibit oxidative stress caused by Alzheimer's disease-related Cu(II)-β-amyloid complexes-cooperative action of phospho-moiety. |
| AID626540 | Inhibition of Cu2-amyloid beta (1 to 16) complex-induced dopamine oxidation by spectrophotometry | 2011 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21 | Vitamin B6s inhibit oxidative stress caused by Alzheimer's disease-related Cu(II)-β-amyloid complexes-cooperative action of phospho-moiety. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (89.77) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||